(Q36286942)

13 August 2017

1 reference

title

Cytotoxic treatment of metastatic breast cancer. Which drugs and drug combinations to use? (English)

1 reference

13 August 2017

0 references

Pfeiffer P

1

1 reference

13 August 2017

Cold S

series ordinal

2

1 reference

13 August 2017

Rose C

series ordinal

3

1 reference

13 August 2017

publication date

1 January 1992

1 reference

13 August 2017

1 reference

13 August 2017

volume

31

1 reference

13 August 2017

issue

2

1 reference

13 August 2017

page(s)

219-224

1 reference

Improving the quality of life during chemotherapy for advanced breast cancer. A comparison of intermittent and continuous treatment strategies.

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F02841869209088906

Does more intense palliative treatment improve overall survival in metastatic breast cancer patients?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869209088906

Does chemotherapy improve survival in advanced breast cancer? A statistical overview

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869209088906

Measurement of quality of life in advanced breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869209088906

A comparison of cyclophosphamide, adriamycin, 5-fluorouracil (CAF) and cyclophosphamide, methotrexate, 5-fluorouracil, vincristine, prednisone (CMFVP) in patients with metastatic breast cancer: a Southeastern Cancer Study Group project

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869209088906

A randomized comparative trial of adriamycin versus methotrexate in combination drug therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869209088906

Current status of epirubicin (Farmorubicin) in the treatment of solid tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869209088906

A randomised comparative trial of mitozantrone/methotrexate/mitomycin C (MMM) and cyclophosphamide/methotrexate/5 FU (CMF) in the treatment of advanced breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869209088906

A randomised trial comparing combination chemotherapy using mitomycin C, mitozantrone and methotrexate (3M) with vincristine, anthracycline and cyclophosphamide (VAC) in advanced breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869209088906

Comparison of short-term and continuous chemotherapy (mitozantrone) for advanced breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869209088906

10.3109/02841869209088906

21 January 2018

Identifiers

DOI

1 reference

13 August 2017

1 reference